Purple biotech appoints life sciences industry investor ori hershkovitz to its board of directors

Rehovot, israel, jan. 06, 2022 (globe newswire) -- purple biotech ltd. ("purple biotech", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the appointment of ori hershkovitz, a long-time life sciences industry investor, to its board of directors.
PPBT Ratings Summary
PPBT Quant Ranking